Isolation of NDM-1-producing Pseudomonas aeruginosa sequence type ST235 from a stem cell transplant patient in Italy, May 2013. 2013

A Carattoli, and D Fortini, and R Galetti, and A Garcia-Fernandez, and G Nardi, and D Orazi, and A Capone, and I Majolino, and A Proia, and B Mariani, and G Parisi, and A Morrone, and N Petrosillo
Istituto Superiore di Sanita, Rome Italy.

We describe the first isolation of an NDM-1-producing Pseudomonas aeruginosa in Italy. In May 2013, a patient with acute lymphoblastic leukaemia and history of prior hospitalisation in Belgrad, Serbia, underwent stem cell transplantation at a tertiary care hospital in Rome, Italy. After transplantion, sepsis by NDM-1-producing P. aeruginosa occurred, leading to septic shock and fatal outcome.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008297 Male Males
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases

Related Publications

A Carattoli, and D Fortini, and R Galetti, and A Garcia-Fernandez, and G Nardi, and D Orazi, and A Capone, and I Majolino, and A Proia, and B Mariani, and G Parisi, and A Morrone, and N Petrosillo
May 2020, Antimicrobial resistance and infection control,
A Carattoli, and D Fortini, and R Galetti, and A Garcia-Fernandez, and G Nardi, and D Orazi, and A Capone, and I Majolino, and A Proia, and B Mariani, and G Parisi, and A Morrone, and N Petrosillo
March 2017, Journal of global antimicrobial resistance,
A Carattoli, and D Fortini, and R Galetti, and A Garcia-Fernandez, and G Nardi, and D Orazi, and A Capone, and I Majolino, and A Proia, and B Mariani, and G Parisi, and A Morrone, and N Petrosillo
January 2020, Emerging microbes & infections,
A Carattoli, and D Fortini, and R Galetti, and A Garcia-Fernandez, and G Nardi, and D Orazi, and A Capone, and I Majolino, and A Proia, and B Mariani, and G Parisi, and A Morrone, and N Petrosillo
December 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
A Carattoli, and D Fortini, and R Galetti, and A Garcia-Fernandez, and G Nardi, and D Orazi, and A Capone, and I Majolino, and A Proia, and B Mariani, and G Parisi, and A Morrone, and N Petrosillo
February 2016, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
A Carattoli, and D Fortini, and R Galetti, and A Garcia-Fernandez, and G Nardi, and D Orazi, and A Capone, and I Majolino, and A Proia, and B Mariani, and G Parisi, and A Morrone, and N Petrosillo
November 2021, Annals of clinical microbiology and antimicrobials,
A Carattoli, and D Fortini, and R Galetti, and A Garcia-Fernandez, and G Nardi, and D Orazi, and A Capone, and I Majolino, and A Proia, and B Mariani, and G Parisi, and A Morrone, and N Petrosillo
June 2022, Journal of global antimicrobial resistance,
A Carattoli, and D Fortini, and R Galetti, and A Garcia-Fernandez, and G Nardi, and D Orazi, and A Capone, and I Majolino, and A Proia, and B Mariani, and G Parisi, and A Morrone, and N Petrosillo
November 2023, Emerging infectious diseases,
A Carattoli, and D Fortini, and R Galetti, and A Garcia-Fernandez, and G Nardi, and D Orazi, and A Capone, and I Majolino, and A Proia, and B Mariani, and G Parisi, and A Morrone, and N Petrosillo
March 2018, Journal of global antimicrobial resistance,
A Carattoli, and D Fortini, and R Galetti, and A Garcia-Fernandez, and G Nardi, and D Orazi, and A Capone, and I Majolino, and A Proia, and B Mariani, and G Parisi, and A Morrone, and N Petrosillo
November 2015, Emerging infectious diseases,
Copied contents to your clipboard!